In the fight against prostate cancer, innovative AI imaging technology is proving to be a game-changer, with Avenda Health and Kasraeian Urology teaming up to bring cutting-edge solutions to patients in Jacksonville and beyond.

Avenda's FDA-cleared Unfold AI is set to revolutionize diagnosis and treatment planning, leveraging advanced imaging techniques and machine learning algorithms to enhance precision.

This groundbreaking technology doesn't just stop at detection—it's a game-changer. In validation studies, Unfold AI identified 159% more cancer than MRI alone, prompting physicians to adjust treatment recommendations in 28% of cases, often towards more localized approaches. This means better outcomes and more personalized care for patients.

For Kasraeian Urology, known for their family-centered approach and comprehensive care, integrating Unfold AI into their practice means a deeper understanding of prostate cancer presentations

Poised to leverage this sophisticated algorithm to its fullest, incorporating detailed data from MRI scans, pathology reports, and patient history for truly personalized treatment plans.

The significance of this partnership, highlighting how Unfold AI expands their access to crucial information, empowering both physicians and patients to make more informed decisions together.

CEO of Avenda Health, this collaboration marks another step towards their mission of revolutionizing healthcare through innovation, with the ultimate goal of making a meaningful impact on the lives of prostate cancer patients.

 

 

Source: prnewswire.com

Report Abuse